Estimates Revisions Middle East Pharmaceutical Industries Company
Stocks
4016
SA160G51UO10
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 57.80 SAR | +0.26% |
|
-3.34% | -9.04% |
| 07-17 | Derayah Financial Starts Avalon Pharma's Coverage at Buy | MT |
| 05-14 | Saudi Arabia's Edaa Executes Securities Quantity Increase for Avalon Pharma | MT |
| 1m. Revenue rev. | 1y. Revenue rev. | 1y. EPS revision | ||
|---|---|---|---|---|
 | - | |||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| ||||
| Average | ||||
| Weighted average by Cap. |
- Stock Market
- Stocks
- 4016 Stock
- Consensus Middle East Pharmaceutical Industries Company
- Estimates Revisions
Select your edition
All financial news and data tailored to specific country editions
